Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
The emergence of Plasmodium falciparum parasites resistant to artemisinins compromises the efficacy of Artemisinin Combination Therapies (ACTs), the global first-line malaria treatment. Artemisinin resistance is a complex genetic trait in which nonsynonymous SNPs in PfK13 cooperate with other geneti...
Main Authors: | Nayak, S, Peto, TJ, Kucharski, M, Tripura, R, Callery, JJ, Quang Huy, DT, Gendrot, M, Lek, D, Nghia, HDT, van der Pluijm, RW, Dong, N, Long, LT, Vongpromek, R, Rekol, H, Hoang Chau, N, Miotto, O, Mukaka, M, Dhorda, M, von Seidlein, L, Imwong, M, Roca, X, Day, NPJ, White, NJ, Dondorp, AM |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Nature Research
2024
|
פריטים דומים
-
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
מאת: Nayak, Sourav, et al.
יצא לאור: (2025) -
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
מאת: Sourav Nayak, et al.
יצא לאור: (2024-12-01) -
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
מאת: Peto, TJ, et al.
יצא לאור: (2022) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
מאת: van der Pluijm, RW, et al.
יצא לאור: (2022) -
Triple artemisinin-based combination therapies for malaria – a new paradigm?
מאת: van der Pluijm, RW, et al.
יצא לאור: (2020)